Anti-c-Abl (Ab-3) Mouse mAb (24-21)

100

mouse

purified antibody

primary antibodies

24-21, monoclonal

liquid

≤0.1% sodium azide as preservative

human, mouse

Calbiochem^®

do not freeze

IgG1

wet ice

2-8℃

100 μg in Plastic ampoule
Please refer to vial label for lot-specific concentration.

Purified mouse monoclonal antibody generated by immunizing BALB/c mice with the specified immunogen and fusing splenocytes with p.3U1 mouse myeloma cells (see application references). Recognizes the v-Abl, the ~145-150 kDa c-Abl, the ~210 kDa Bcr-Abl (CML), and the ~190 kDa Bcr-Abl (ALL) proteins.
Anti-c-Abl (Ab-3), mouse monoclonal, clone 24-21, recognizes the ~145 kDa human and ~150 kDa mouse c-Abl. It is validated for Western blotting, immunofluorescence, and immunoprecipitation.
Recognizes the ~145 kDa human c-Abl, the ~150 kDa mouse c-Abl, v-Abl, and the Bcr/Abl translocation products in ALL (~190 kDa) and CML (~210 kDa). Does not inhibit protein tyrosine kinase activity.

Antibody Target Gene Symbol: ABL1

Target Synonym: ABL, AI325092, bcr/abl, C-ABL, C-ABL 1B, CABL1, E430008G22Rik, JTK7, MGC117749, p145Abl, p150, v-abl

Entrez Gene Name: c-abl oncogene 1, receptor tyrosine kinase

Hu Entrez ID: 25 (Related Antibodies: PK1006PK1013OP19)

Mu Entrez ID: 11350

Rat Entrez ID: 311860

a recombinant protein consisting of the carboxyl region of v-abl protein fused to TrpE

Immunoblotting (1-5 µg/ml)

Immunofluorescence (see application references)

Immunoprecipitation (1-2 µg/sample)

Neutralization Studies (not recommended)

Toxicity: Standard Handling (A)

In 0.05 M sodium phosphate buffer, 0.2% gelatin, pH 7.5.

Positive Control
K562 (human bcr/abl), HL-60 (normal abl), and ANN-1 (murine abl) cells

Does not inhibit protein tyrosine kinase activity. Detects human c-Abl (145 kDa), mouse c-Abl (150 kDa), v-Abl, and the Bcr/Abl translocation products in ALL (~210 kDa) and CML (~190 kDa). HL-60 and NIH3T3 cells contain normal, non-rearranged protein. Antibody should be titrated for optimal results in individual sample types.
Wiedemann, L.M., et al. 1988. Blood71, 349.
Stam, K., et al. 1985. N. Engl. J. Med.313, 1429.
Konopka, J.B., et al. 1984. Cell37, 1035.
Prywes, R., et al. 1983. Cell34, 569.
de Klein, A., et al. 1982. Nature300, 765.
Reynolds, F.H., Jr., et al. 1980. J. Virol.36, 374.
Reynolds, F.H., Jr., et al. 1978. Proc. Natl. Acad. Sci. USA75, 3974.
Witte, O.N., et al. 1978. Proc. Natl. Acad. Sci. USA75, 2488.
Abelson, H.T. and Rabstein, L.S. 1970. Cancer Res.30, 2213.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

12 - Non Combustible Liquids

nwg